bismuth has been researched along with yttrium radioisotopes in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gansow, OA | 1 |
| Waldmann, TA | 2 |
| Brechbiel, M; Kennel, SJ; Mirzadeh, S; Stabin, M; Yoriyaz, H | 1 |
| Apostolidis, C; Becker, W; Béhé, M; Behr, TM; Fayyazi, A; Goldenberg, DM; Gratz, S; Koch, L; Molinet, R; Stabin, MG; Strutz, F; Wehrmann, E; Wieland, E | 1 |
| Apostolidis, C; Esaias, C; Hobbs, RF; Huso, DL; Morgenstern, A; Sgouros, G; Song, H; Vajravelu, R | 1 |
| Bednarz, B; Lee, D; Li, M; Schultz, MK | 1 |
3 review(s) available for bismuth and yttrium radioisotopes
| Article | Year |
|---|---|
Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates.
Topics: Antibodies, Monoclonal; Bismuth; Chelating Agents; Humans; Immunotherapy; Indium Radioisotopes; Isotope Labeling; Ligands; Molecular Structure; Radioisotopes; Radionuclide Imaging; Radiotherapy; Yttrium Radioisotopes | 1991 |
Genetically engineered monoclonal antibodies armed with radionuclides.
Topics: Animals; Antibodies, Monoclonal; Autoimmune Diseases; Bismuth; CD4 Antigens; CD4-Positive T-Lymphocytes; Gene Expression Regulation, Neoplastic; Humans; Immunotoxins; Leukemia-Lymphoma, Adult T-Cell; Mice; Neoplasm Proteins; Neoplasms; Protein Engineering; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Yttrium Radioisotopes | 1993 |
Anti-IL-2 receptor monoclonal antibody (anti-Tac) treatment of T-cell lymphoma.
Topics: ADP Ribose Transferases; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Specificity; Antibody-Dependent Cell Cytotoxicity; Bacterial Toxins; Bismuth; Exotoxins; Gene Expression Regulation, Neoplastic; HTLV-I Infections; Humans; Immunologic Deficiency Syndromes; Immunotoxins; Leukemia-Lymphoma, Adult T-Cell; Mice; Molecular Sequence Data; Neoplasm Proteins; Protein Engineering; Pseudomonas aeruginosa Exotoxin A; Radioisotopes; Receptors, Interleukin-2; Virulence Factors; Yttrium Radioisotopes | 1994 |
4 other study(ies) available for bismuth and yttrium radioisotopes
| Article | Year |
|---|---|
Treatment of lung tumor colonies with 90Y targeted to blood vessels: comparison with the alpha-particle emitter 213Bi.
Topics: Animals; Antibodies, Monoclonal; Bismuth; Dose-Response Relationship, Radiation; Female; Isothiocyanates; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, SCID; Pentetic Acid; Radioisotopes; Radiopharmaceuticals; Yttrium Radioisotopes | 1999 |
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Topics: Animals; Antibodies, Monoclonal; Bismuth; Bone and Bones; Colonic Neoplasms; Female; Half-Life; Humans; Immunoglobulin Fab Fragments; Kidney; Linear Energy Transfer; Mice; Mice, Nude; Radioimmunotherapy; Radioisotopes; Relative Biological Effectiveness; Tissue Distribution; Tumor Cells, Cultured; Yttrium Radioisotopes | 1999 |
Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y.
Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Bismuth; Female; Immunotoxins; Isotope Labeling; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Radioimmunotherapy; Radioisotopes; Rats; Receptor, ErbB-2; Tissue Distribution; Yttrium Radioisotopes | 2009 |
Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
Topics: Actinium; Alpha Particles; Beta Particles; Bismuth; Dose-Response Relationship, Radiation; Humans; Lead Radioisotopes; Lutetium; Neoplasm Metastasis; Neoplasms; Radioisotopes; Yttrium Radioisotopes | 2018 |